<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>VOVECA — Dedicated to Life</title>
<meta name="description" content="Voveca is a longevity science research hub exploring the frontier of human immortality. Founded by Alice Frolov.">
<meta property="og:title" content="VOVECA — Dedicated to Life">
<meta property="og:description" content="The science of conquering death. Longevity research, aging biology, and the pursuit of human immortality.">
<meta property="og:type" content="website">
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,300;0,400;0,600;1,300;1,400&family=Syne:wght@400;700;800&family=Space+Mono:ital@0;1&display=swap" rel="stylesheet">
<style>
  :root {
    --black: #030508;
    --deep: #060d1a;
    --navy: #0a1628;
    --blue: #0d2040;
    --accent: #00e5ff;
    --white: #f0f4ff;
    --muted: #8892a4;
    --text: #c8d4e8;
    --gold: #d4af37;
  }

  *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }
  html { scroll-behavior: smooth; }

  body {
    background: var(--black);
    color: var(--text);
    font-family: 'Cormorant Garamond', serif;
    font-size: 18px;
    overflow-x: hidden;
    cursor: none;
  }

  @media (pointer: coarse) {
    body { cursor: auto; }
    .cursor, .cursor-ring { display: none; }
  }

  /* Custom cursor */
  .cursor {
    width: 8px; height: 8px;
    background: var(--accent);
    border-radius: 50%;
    position: fixed;
    pointer-events: none;
    z-index: 9999;
    transition: transform 0.1s;
    mix-blend-mode: screen;
  }
  .cursor-ring {
    width: 40px; height: 40px;
    border: 1px solid rgba(0,229,255,0.4);
    border-radius: 50%;
    position: fixed;
    pointer-events: none;
    z-index: 9998;
    transition: all 0.15s ease;
    transform: translate(-50%, -50%);
  }

  /* Noise overlay */
  body::before {
    content: '';
    position: fixed;
    inset: 0;
    background-image: url("data:image/svg+xml,%3Csvg viewBox='0 0 256 256' xmlns='http://www.w3.org/2000/svg'%3E%3Cfilter id='noise'%3E%3CfeTurbulence type='fractalNoise' baseFrequency='0.9' numOctaves='4' stitchTiles='stitch'/%3E%3C/filter%3E%3Crect width='100%25' height='100%25' filter='url(%23noise)' opacity='0.04'/%3E%3C/svg%3E");
    opacity: 0.4;
    pointer-events: none;
    z-index: 1;
  }

  /* ====== NAVIGATION ====== */
  nav {
    position: fixed;
    top: 0; left: 0; right: 0;
    z-index: 100;
    padding: 24px 60px;
    display: flex;
    justify-content: space-between;
    align-items: center;
    background: linear-gradient(to bottom, rgba(3,5,8,0.95), transparent);
    backdrop-filter: blur(2px);
  }

  .logo {
    font-family: 'Syne', sans-serif;
    font-weight: 800;
    font-size: 22px;
    letter-spacing: 0.3em;
    color: var(--white);
    text-decoration: none;
    display: flex;
    align-items: center;
    gap: 12px;
  }

  .logo-mark {
    width: 32px;
    height: 32px;
    position: relative;
    display: flex;
    align-items: center;
    justify-content: center;
  }

  .logo-mark::before {
    content: '';
    position: absolute;
    width: 100%;
    height: 100%;
    border: 1.5px solid var(--accent);
    border-radius: 50%;
    animation: logoPulse 3s ease-in-out infinite;
  }

  .logo-mark::after {
    content: '';
    position: absolute;
    width: 60%;
    height: 60%;
    border: 1.5px solid rgba(0,229,255,0.4);
    border-radius: 50%;
  }

  .logo-dot {
    width: 6px;
    height: 6px;
    background: var(--accent);
    border-radius: 50%;
    position: relative;
    z-index: 1;
  }

  @keyframes logoPulse {
    0%, 100% { transform: scale(1); opacity: 1; }
    50% { transform: scale(1.2); opacity: 0.6; }
  }

  .logo-text { letter-spacing: 0.35em; }
  .logo-text span { color: var(--accent); }

  .nav-links {
    display: flex;
    gap: 40px;
    list-style: none;
  }
  .nav-links a {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.15em;
    color: var(--muted);
    text-decoration: none;
    text-transform: uppercase;
    transition: color 0.3s;
  }
  .nav-links a:hover { color: var(--accent); }

  .nav-menu-btn {
    display: none;
    background: none;
    border: 1px solid rgba(0,229,255,0.3);
    color: var(--accent);
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.15em;
    padding: 8px 16px;
    cursor: pointer;
    text-transform: uppercase;
  }

  /* ====== HERO ====== */
  .hero {
    min-height: 100vh;
    display: flex;
    flex-direction: column;
    justify-content: center;
    align-items: center;
    text-align: center;
    position: relative;
    overflow: hidden;
    padding: 120px 40px 80px;
  }

  .hero-bg {
    position: absolute;
    inset: 0;
    background:
      radial-gradient(ellipse 80% 60% at 50% 100%, rgba(13,32,64,0.8) 0%, transparent 70%),
      radial-gradient(ellipse 60% 40% at 20% 20%, rgba(0,229,255,0.06) 0%, transparent 60%),
      radial-gradient(ellipse 40% 30% at 80% 30%, rgba(0,229,255,0.04) 0%, transparent 50%),
      var(--black);
  }

  .grid-lines {
    position: absolute;
    inset: 0;
    background-image:
      linear-gradient(rgba(0,229,255,0.03) 1px, transparent 1px),
      linear-gradient(90deg, rgba(0,229,255,0.03) 1px, transparent 1px);
    background-size: 80px 80px;
    animation: gridMove 20s linear infinite;
  }
  @keyframes gridMove {
    0% { transform: translateY(0); }
    100% { transform: translateY(80px); }
  }

  /* Voveca logo hero */
  .hero-logo-display {
    position: relative;
    z-index: 2;
    margin-bottom: 48px;
    animation: fadeInUp 1s 0.1s both;
  }

  .hero-logo-circles {
    position: relative;
    width: 120px;
    height: 120px;
    margin: 0 auto 24px;
  }

  .circle-outer {
    position: absolute;
    inset: 0;
    border: 1px solid rgba(0,229,255,0.2);
    border-radius: 50%;
    animation: rotate 20s linear infinite;
  }

  .circle-mid {
    position: absolute;
    inset: 20px;
    border: 1px solid rgba(0,229,255,0.35);
    border-radius: 50%;
    animation: rotate 15s linear infinite reverse;
  }

  .circle-inner {
    position: absolute;
    inset: 40px;
    border: 1.5px solid var(--accent);
    border-radius: 50%;
    animation: pulsate 3s ease-in-out infinite;
  }

  .circle-core {
    position: absolute;
    inset: 52px;
    background: var(--accent);
    border-radius: 50%;
    box-shadow: 0 0 20px rgba(0,229,255,0.6), 0 0 40px rgba(0,229,255,0.3);
  }

  @keyframes rotate {
    from { transform: rotate(0deg); }
    to { transform: rotate(360deg); }
  }

  @keyframes pulsate {
    0%, 100% { opacity: 1; transform: scale(1); }
    50% { opacity: 0.6; transform: scale(0.95); }
  }

  .hero-eyebrow {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.4em;
    color: var(--accent);
    text-transform: uppercase;
    margin-bottom: 32px;
    position: relative;
    z-index: 2;
    animation: fadeInUp 1s 0.2s both;
  }
  .hero-eyebrow::before, .hero-eyebrow::after {
    content: '—';
    margin: 0 16px;
    color: rgba(0,229,255,0.4);
  }

  h1 {
    font-family: 'Cormorant Garamond', serif;
    font-size: clamp(56px, 9vw, 130px);
    font-weight: 300;
    line-height: 0.9;
    color: var(--white);
    position: relative;
    z-index: 2;
    animation: fadeInUp 1s 0.4s both;
    letter-spacing: -0.02em;
  }
  h1 em {
    font-style: italic;
    color: var(--accent);
    display: block;
  }

  .hero-sub {
    max-width: 600px;
    margin: 40px auto 0;
    font-size: 20px;
    font-weight: 300;
    color: var(--muted);
    line-height: 1.8;
    position: relative;
    z-index: 2;
    animation: fadeInUp 1s 0.6s both;
  }

  .hero-cta {
    display: flex;
    gap: 20px;
    margin-top: 60px;
    position: relative;
    z-index: 2;
    animation: fadeInUp 1s 0.8s both;
    flex-wrap: wrap;
    justify-content: center;
  }

  .btn-primary {
    font-family: 'Space Mono', monospace;
    font-size: 12px;
    letter-spacing: 0.2em;
    text-transform: uppercase;
    padding: 16px 40px;
    background: var(--accent);
    color: var(--black);
    border: none;
    text-decoration: none;
    font-weight: 700;
    transition: all 0.3s;
    position: relative;
    overflow: hidden;
  }
  .btn-primary span { position: relative; z-index: 1; }
  .btn-primary::before {
    content: '';
    position: absolute;
    inset: 0;
    background: white;
    transform: translateX(-100%);
    transition: transform 0.3s;
  }
  .btn-primary:hover::before { transform: translateX(0); }

  .btn-secondary {
    font-family: 'Space Mono', monospace;
    font-size: 12px;
    letter-spacing: 0.2em;
    text-transform: uppercase;
    padding: 16px 40px;
    background: transparent;
    color: var(--white);
    border: 1px solid rgba(255,255,255,0.2);
    text-decoration: none;
    transition: all 0.3s;
  }
  .btn-secondary:hover {
    border-color: var(--accent);
    color: var(--accent);
  }

  .scroll-indicator {
    position: absolute;
    bottom: 40px;
    left: 50%;
    transform: translateX(-50%);
    z-index: 2;
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 8px;
    animation: fadeInUp 1s 1.2s both;
  }
  .scroll-line {
    width: 1px;
    height: 60px;
    background: linear-gradient(to bottom, transparent, var(--accent));
    animation: scrollLine 2s ease-in-out infinite;
  }
  @keyframes scrollLine {
    0% { transform: scaleY(0); transform-origin: top; }
    50% { transform: scaleY(1); transform-origin: top; }
    51% { transform: scaleY(1); transform-origin: bottom; }
    100% { transform: scaleY(0); transform-origin: bottom; }
  }

  @keyframes fadeInUp {
    from { opacity: 0; transform: translateY(30px); }
    to { opacity: 1; transform: translateY(0); }
  }

  /* ====== STATS BAR ====== */
  .stats-bar {
    background: var(--deep);
    border-top: 1px solid rgba(0,229,255,0.08);
    border-bottom: 1px solid rgba(0,229,255,0.08);
    padding: 40px 60px;
    display: grid;
    grid-template-columns: repeat(4, 1fr);
    gap: 40px;
  }
  .stat-item {
    text-align: center;
    border-right: 1px solid rgba(255,255,255,0.05);
  }
  .stat-item:last-child { border-right: none; }
  .stat-num {
    font-family: 'Syne', sans-serif;
    font-size: clamp(32px, 4vw, 56px);
    font-weight: 800;
    color: var(--white);
    display: block;
    line-height: 1;
  }
  .stat-num span { color: var(--accent); }
  .stat-label {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.2em;
    color: var(--muted);
    text-transform: uppercase;
    display: block;
    margin-top: 8px;
  }

  /* ====== SECTIONS ====== */
  section {
    padding: 120px 60px;
    position: relative;
  }

  .section-label {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.3em;
    color: var(--accent);
    text-transform: uppercase;
    display: flex;
    align-items: center;
    gap: 16px;
    margin-bottom: 32px;
  }
  .section-label::after {
    content: '';
    flex: 1;
    max-width: 60px;
    height: 1px;
    background: var(--accent);
    opacity: 0.4;
  }

  h2 {
    font-family: 'Cormorant Garamond', serif;
    font-size: clamp(40px, 6vw, 80px);
    font-weight: 300;
    color: var(--white);
    line-height: 1;
    margin-bottom: 60px;
    letter-spacing: -0.02em;
  }
  h2 em {
    font-style: italic;
    color: var(--accent);
  }

  /* ====== ABOUT SECTION ====== */
  .about-section {
    background: var(--deep);
    display: grid;
    grid-template-columns: 1fr 1fr;
    gap: 80px;
    align-items: center;
  }

  .about-text p {
    font-size: 20px;
    line-height: 1.9;
    color: var(--text);
    margin-bottom: 24px;
    font-weight: 300;
  }

  .about-founder {
    border-left: 1px solid rgba(0,229,255,0.2);
    padding-left: 40px;
    margin-top: 48px;
  }

  .founder-name {
    font-family: 'Syne', sans-serif;
    font-size: 20px;
    font-weight: 700;
    color: var(--white);
    letter-spacing: 0.1em;
  }

  .founder-title {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.2em;
    color: var(--accent);
    text-transform: uppercase;
    margin-top: 6px;
    display: block;
  }

  .founder-bio {
    font-size: 16px;
    color: var(--muted);
    line-height: 1.8;
    margin-top: 16px;
  }

  .about-visual {
    position: relative;
    height: 500px;
    display: flex;
    align-items: center;
    justify-content: center;
  }

  .dna-visual {
    position: relative;
    width: 200px;
    height: 400px;
  }

  .dna-strand {
    position: absolute;
    width: 100%;
    height: 100%;
  }

  /* ====== HALLMARKS ====== */
  .hallmarks-section { background: var(--black); }

  .hallmarks-grid {
    display: grid;
    grid-template-columns: repeat(3, 1fr);
    gap: 2px;
    background: rgba(0,229,255,0.05);
    border: 1px solid rgba(0,229,255,0.08);
  }

  .hallmark-card {
    background: var(--black);
    padding: 40px;
    position: relative;
    overflow: hidden;
    transition: background 0.3s;
  }
  .hallmark-card::before {
    content: '';
    position: absolute;
    top: 0; left: 0; right: 0;
    height: 2px;
    background: var(--accent);
    transform: scaleX(0);
    transform-origin: left;
    transition: transform 0.4s;
  }
  .hallmark-card:hover { background: var(--deep); }
  .hallmark-card:hover::before { transform: scaleX(1); }

  .hallmark-num {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    color: var(--accent);
    letter-spacing: 0.2em;
    margin-bottom: 20px;
    opacity: 0.6;
  }

  .hallmark-card h3 {
    font-family: 'Cormorant Garamond', serif;
    font-size: 26px;
    font-weight: 400;
    color: var(--white);
    margin-bottom: 16px;
    line-height: 1.2;
  }

  .hallmark-card p {
    font-size: 15px;
    color: var(--muted);
    line-height: 1.7;
  }

  /* ====== INTERVENTIONS ====== */
  .interventions-section { background: var(--deep); }

  .tabs {
    display: flex;
    gap: 0;
    margin-bottom: 60px;
    border-bottom: 1px solid rgba(255,255,255,0.08);
    overflow-x: auto;
  }

  .tab-btn {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.15em;
    text-transform: uppercase;
    padding: 16px 32px;
    background: none;
    border: none;
    color: var(--muted);
    cursor: pointer;
    transition: all 0.3s;
    white-space: nowrap;
    border-bottom: 2px solid transparent;
    margin-bottom: -1px;
  }
  .tab-btn.active, .tab-btn:hover {
    color: var(--accent);
    border-bottom-color: var(--accent);
  }

  .tab-content { display: none; }
  .tab-content.active { display: grid; grid-template-columns: 1fr 1fr; gap: 60px; align-items: start; }

  .intervention-info h3 {
    font-family: 'Cormorant Garamond', serif;
    font-size: 44px;
    font-weight: 300;
    color: var(--white);
    margin-bottom: 24px;
    line-height: 1;
  }

  .intervention-info p {
    font-size: 18px;
    color: var(--text);
    line-height: 1.8;
    margin-bottom: 20px;
  }

  .intervention-meta {
    display: grid;
    grid-template-columns: 1fr 1fr;
    gap: 20px;
    margin-top: 40px;
  }

  .meta-item {
    padding: 20px;
    border: 1px solid rgba(0,229,255,0.1);
    background: rgba(0,229,255,0.02);
  }

  .meta-label {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.2em;
    color: var(--accent);
    text-transform: uppercase;
    display: block;
    margin-bottom: 8px;
  }

  .meta-value {
    font-family: 'Cormorant Garamond', serif;
    font-size: 20px;
    color: var(--white);
  }

  .intervention-cards {
    display: flex;
    flex-direction: column;
    gap: 16px;
  }

  .intervention-card {
    padding: 24px;
    border: 1px solid rgba(255,255,255,0.06);
    background: rgba(0,229,255,0.02);
    transition: all 0.3s;
    cursor: default;
  }
  .intervention-card:hover {
    border-color: rgba(0,229,255,0.2);
    background: rgba(0,229,255,0.04);
  }

  .intervention-card h4 {
    font-family: 'Syne', sans-serif;
    font-size: 14px;
    font-weight: 700;
    color: var(--white);
    letter-spacing: 0.1em;
    margin-bottom: 8px;
  }

  .intervention-card p {
    font-size: 14px;
    color: var(--muted);
    line-height: 1.6;
  }

  /* ====== ROADMAP ====== */
  .roadmap-section { background: var(--black); }

  .timeline {
    position: relative;
    padding-left: 80px;
  }
  .timeline::before {
    content: '';
    position: absolute;
    left: 16px;
    top: 0; bottom: 0;
    width: 1px;
    background: linear-gradient(to bottom, var(--accent), transparent);
    opacity: 0.3;
  }

  .timeline-item {
    position: relative;
    margin-bottom: 60px;
  }
  .timeline-item::before {
    content: '';
    position: absolute;
    left: -72px;
    top: 8px;
    width: 10px;
    height: 10px;
    border-radius: 50%;
    background: var(--accent);
    box-shadow: 0 0 12px rgba(0,229,255,0.6);
  }

  .timeline-year {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    color: var(--accent);
    letter-spacing: 0.2em;
    margin-bottom: 12px;
  }

  .timeline-item h3 {
    font-family: 'Cormorant Garamond', serif;
    font-size: 32px;
    font-weight: 400;
    color: var(--white);
    margin-bottom: 16px;
    line-height: 1.1;
  }

  .timeline-item p {
    font-size: 16px;
    color: var(--muted);
    line-height: 1.8;
    max-width: 600px;
  }

  /* ====== FAQ ====== */
  .faq-section { background: var(--deep); }

  .accordion-item {
    border-bottom: 1px solid rgba(255,255,255,0.06);
  }

  .accordion-header {
    display: flex;
    justify-content: space-between;
    align-items: center;
    padding: 28px 0;
    cursor: pointer;
    transition: color 0.3s;
  }
  .accordion-header:hover h4 { color: var(--accent); }

  .accordion-header h4 {
    font-family: 'Cormorant Garamond', serif;
    font-size: 24px;
    font-weight: 400;
    color: var(--white);
    transition: color 0.3s;
    line-height: 1.3;
    padding-right: 40px;
  }

  .accordion-icon {
    font-family: 'Space Mono', monospace;
    font-size: 20px;
    color: var(--accent);
    transition: transform 0.3s;
    flex-shrink: 0;
  }
  .accordion-item.open .accordion-icon { transform: rotate(45deg); }

  .accordion-body {
    max-height: 0;
    overflow: hidden;
    transition: max-height 0.4s ease;
  }
  .accordion-item.open .accordion-body { max-height: 400px; }

  .accordion-body-inner {
    padding-bottom: 28px;
    font-size: 17px;
    color: var(--muted);
    line-height: 1.9;
  }

  /* ====== COMPANIES ====== */
  .companies-section {
    background: var(--black);
    text-align: center;
  }

  .companies-grid {
    display: grid;
    grid-template-columns: repeat(4, 1fr);
    gap: 2px;
    background: rgba(0,229,255,0.05);
    border: 1px solid rgba(0,229,255,0.08);
    margin-top: 60px;
  }

  .company-cell {
    background: var(--black);
    padding: 32px 24px;
    display: flex;
    flex-direction: column;
    gap: 8px;
    transition: background 0.3s;
    text-align: left;
  }
  .company-cell:hover { background: var(--deep); }

  .company-name {
    font-family: 'Syne', sans-serif;
    font-size: 13px;
    font-weight: 800;
    color: var(--white);
    letter-spacing: 0.15em;
  }

  .company-focus {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    color: var(--accent);
    letter-spacing: 0.15em;
    text-transform: uppercase;
  }

  .company-desc {
    font-size: 13px;
    color: var(--muted);
    line-height: 1.6;
    margin-top: 4px;
  }

  /* ====== MANIFESTO ====== */
  .manifesto {
    background: var(--deep);
    border-top: 1px solid rgba(0,229,255,0.08);
    border-bottom: 1px solid rgba(0,229,255,0.08);
    padding: 120px 60px;
    text-align: center;
  }

  .manifesto-inner { max-width: 800px; margin: 0 auto; }

  .manifesto-quote {
    font-family: 'Cormorant Garamond', serif;
    font-size: clamp(28px, 4vw, 48px);
    font-weight: 300;
    color: var(--white);
    line-height: 1.4;
    margin-bottom: 40px;
    font-style: italic;
  }
  .manifesto-quote em {
    font-style: normal;
    color: var(--accent);
    text-decoration: underline;
    text-decoration-color: rgba(0,229,255,0.3);
  }

  /* ====== FOOTER ====== */
  footer {
    background: var(--black);
    padding: 60px;
    border-top: 1px solid rgba(255,255,255,0.04);
    display: grid;
    grid-template-columns: auto 1fr auto;
    gap: 40px;
    align-items: center;
  }

  .footer-logo {
    font-family: 'Syne', sans-serif;
    font-size: 24px;
    font-weight: 800;
    color: var(--white);
    letter-spacing: 0.3em;
    display: flex;
    align-items: center;
    gap: 10px;
  }
  .footer-logo span { color: var(--accent); }

  .footer-logo-dot {
    width: 8px;
    height: 8px;
    background: var(--accent);
    border-radius: 50%;
    box-shadow: 0 0 10px rgba(0,229,255,0.6);
  }

  .footer-text {
    font-family: 'Space Mono', monospace;
    font-size: 11px;
    color: var(--muted);
    letter-spacing: 0.1em;
    line-height: 1.8;
    text-align: center;
  }

  .footer-founder {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    color: var(--muted);
    letter-spacing: 0.15em;
    text-align: right;
  }
  .footer-founder strong {
    color: var(--white);
    display: block;
    font-size: 13px;
    letter-spacing: 0.2em;
    margin-bottom: 4px;
  }

  .footer-links {
    display: flex;
    gap: 32px;
    justify-content: center;
    margin-top: 40px;
    grid-column: 1 / -1;
    border-top: 1px solid rgba(255,255,255,0.04);
    padding-top: 32px;
  }
  .footer-links a {
    font-family: 'Space Mono', monospace;
    font-size: 10px;
    letter-spacing: 0.2em;
    color: var(--muted);
    text-decoration: none;
    text-transform: uppercase;
    transition: color 0.3s;
  }
  .footer-links a:hover { color: var(--accent); }

  /* ====== FADE IN ====== */
  .fade-in {
    opacity: 0;
    transform: translateY(24px);
    transition: opacity 0.7s ease, transform 0.7s ease;
  }
  .fade-in.visible {
    opacity: 1;
    transform: translateY(0);
  }

  /* ====== MOBILE ====== */
  @media (max-width: 768px) {
    nav {
      padding: 20px 24px;
    }
    .nav-links { display: none; }
    .nav-menu-btn { display: block; }

    section { padding: 80px 24px; }

    .stats-bar {
      padding: 32px 24px;
      grid-template-columns: repeat(2, 1fr);
      gap: 24px;
    }
    .stat-item { border-right: none; border-bottom: 1px solid rgba(255,255,255,0.05); padding-bottom: 24px; }
    .stat-item:nth-child(3), .stat-item:nth-child(4) { border-bottom: none; }

    .about-section { grid-template-columns: 1fr; gap: 40px; }
    .about-visual { height: 200px; }

    .hallmarks-grid { grid-template-columns: 1fr; }

    .tab-content.active { grid-template-columns: 1fr; }

    .companies-grid { grid-template-columns: repeat(2, 1fr); }

    .timeline { padding-left: 40px; }

    footer {
      padding: 40px 24px;
      grid-template-columns: 1fr;
      text-align: center;
    }
    .footer-founder { text-align: center; }
    .footer-links { flex-wrap: wrap; gap: 20px; }

    .hero-cta { flex-direction: column; align-items: center; }

    .manifesto { padding: 80px 24px; }
  }
</style>
</head>
<body>

<div class="cursor" id="cursor"></div>
<div class="cursor-ring" id="cursorRing"></div>

<!-- Navigation -->
<nav>
  <a href="#" class="logo">
    <div class="logo-mark">
      <div class="logo-dot"></div>
    </div>
    <span class="logo-text">VO<span>VE</span>CA</span>
  </a>
  <ul class="nav-links">
    <li><a href="#aging">Science</a></li>
    <li><a href="#interventions">Interventions</a></li>
    <li><a href="#roadmap">Roadmap</a></li>
    <li><a href="#faq">FAQ</a></li>
    <li><a href="#about">About</a></li>
  </ul>
  <button class="nav-menu-btn">Menu</button>
</nav>

<!-- Hero -->
<section class="hero">
  <div class="hero-bg"></div>
  <div class="grid-lines"></div>

  <div class="hero-logo-display">
    <div class="hero-logo-circles">
      <div class="circle-outer"></div>
      <div class="circle-mid"></div>
      <div class="circle-inner"></div>
      <div class="circle-core"></div>
    </div>
  </div>

  <div class="hero-eyebrow">Dedicated to Life</div>

  <h1>
    Death is
    <em>not inevitable.</em>
  </h1>

  <p class="hero-sub">
    Voveca is a longevity science research hub exploring the frontier of human immortality — where biology meets the audacity to live forever.
  </p>

  <div class="hero-cta">
    <a href="#aging" class="btn-primary"><span>Explore the Science</span></a>
    <a href="#about" class="btn-secondary">About Voveca</a>
  </div>

  <div class="scroll-indicator">
    <div class="scroll-line"></div>
  </div>
</section>

<!-- Stats -->
<div class="stats-bar">
  <div class="stat-item">
    <span class="stat-num" id="stat1">0<span>T</span></span>
    <span class="stat-label">Cells in Human Body</span>
  </div>
  <div class="stat-item">
    <span class="stat-num" id="stat2">0</span>
    <span class="stat-label">Hallmarks of Aging</span>
  </div>
  <div class="stat-item">
    <span class="stat-num" id="stat3">$0<span>B+</span></span>
    <span class="stat-label">Longevity Investment</span>
  </div>
  <div class="stat-item">
    <span class="stat-num" id="stat4">0</span>
    <span class="stat-label">Target Year — Escape Velocity</span>
  </div>
</div>

<!-- About -->
<section class="about-section" id="about">
  <div class="about-text">
    <div class="section-label fade-in">00 — Foundation</div>
    <h2 class="fade-in">What is <em>Voveca</em></h2>
    <div class="fade-in">
      <p>Voveca is dedicated to the scientific pursuit of defeating death. We believe aging is not an inevitability — it is a biological process, and biological processes can be understood, intervened upon, and ultimately reversed.</p>
      <p>This is an open-source longevity research hub built for scientists, researchers, and curious minds who refuse to accept that death is the default outcome of a human life.</p>
    </div>
    <div class="about-founder fade-in">
      <div class="founder-name">Alice Frolov</div>
      <span class="founder-title">Founder & Researcher — Aging Biology</span>
      <p class="founder-bio">Gerontology researcher and longevity science communicator. Building Voveca to make the science of immortality accessible to the world's best scientific minds.</p>
    </div>
  </div>
  <div class="about-visual fade-in">
    <svg class="dna-strand" viewBox="0 0 200 400" fill="none" xmlns="http://www.w3.org/2000/svg" opacity="0.4">
      <defs>
        <linearGradient id="dnaGrad" x1="0" y1="0" x2="0" y2="1">
          <stop offset="0%" stop-color="#00e5ff" stop-opacity="0.8"/>
          <stop offset="100%" stop-color="#00e5ff" stop-opacity="0"/>
        </linearGradient>
      </defs>
      <!-- Left strand -->
      <path d="M60,10 Q140,50 60,90 Q-20,130 60,170 Q140,210 60,250 Q-20,290 60,330 Q140,370 60,410" stroke="url(#dnaGrad)" stroke-width="1.5" fill="none"/>
      <!-- Right strand -->
      <path d="M140,10 Q60,50 140,90 Q220,130 140,170 Q60,210 140,250 Q220,290 140,330 Q60,370 140,410" stroke="url(#dnaGrad)" stroke-width="1.5" fill="none"/>
      <!-- Rungs -->
      <line x1="60" y1="30" x2="140" y2="30" stroke="#00e5ff" stroke-width="1" opacity="0.3"/>
      <line x1="75" y1="50" x2="125" y2="50" stroke="#00e5ff" stroke-width="1" opacity="0.5"/>
      <line x1="90" y1="70" x2="110" y2="70" stroke="#00e5ff" stroke-width="1" opacity="0.7"/>
      <line x1="100" y1="90" x2="100" y2="90" stroke="#00e5ff" stroke-width="3" opacity="0.9"/>
      <line x1="90" y1="110" x2="110" y2="110" stroke="#00e5ff" stroke-width="1" opacity="0.7"/>
      <line x1="75" y1="130" x2="125" y2="130" stroke="#00e5ff" stroke-width="1" opacity="0.5"/>
      <line x1="60" y1="150" x2="140" y2="150" stroke="#00e5ff" stroke-width="1" opacity="0.3"/>
      <line x1="75" y1="170" x2="125" y2="170" stroke="#00e5ff" stroke-width="1" opacity="0.5"/>
      <line x1="90" y1="190" x2="110" y2="190" stroke="#00e5ff" stroke-width="1" opacity="0.7"/>
      <line x1="100" y1="210" x2="100" y2="210" stroke="#00e5ff" stroke-width="3" opacity="0.9"/>
      <line x1="90" y1="230" x2="110" y2="230" stroke="#00e5ff" stroke-width="1" opacity="0.7"/>
      <line x1="75" y1="250" x2="125" y2="250" stroke="#00e5ff" stroke-width="1" opacity="0.5"/>
      <line x1="60" y1="270" x2="140" y2="270" stroke="#00e5ff" stroke-width="1" opacity="0.3"/>
      <line x1="75" y1="290" x2="125" y2="290" stroke="#00e5ff" stroke-width="1" opacity="0.5"/>
      <line x1="90" y1="310" x2="110" y2="310" stroke="#00e5ff" stroke-width="1" opacity="0.7"/>
      <line x1="100" y1="330" x2="100" y2="330" stroke="#00e5ff" stroke-width="3" opacity="0.9"/>
    </svg>
  </div>
</section>

<!-- Hallmarks -->
<section class="hallmarks-section" id="aging">
  <div class="section-label fade-in">01 — The Enemy</div>
  <h2 class="fade-in">The 12 Hallmarks<br>of <em>Aging</em></h2>
  <div class="hallmarks-grid">
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">01</div>
      <h3>Genomic Instability</h3>
      <p>DNA damage accumulates over time from environmental and metabolic sources, driving mutations that impair cellular function.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">02</div>
      <h3>Telomere Attrition</h3>
      <p>Protective caps on chromosomes shorten with each cell division, eventually triggering senescence or apoptosis.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">03</div>
      <h3>Epigenetic Alterations</h3>
      <p>Patterns of gene expression drift away from youthful states, silencing critical genes and activating harmful ones.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">04</div>
      <h3>Loss of Proteostasis</h3>
      <p>The system that folds, maintains and clears proteins deteriorates, allowing toxic aggregates to accumulate in cells.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">05</div>
      <h3>Disabled Macroautophagy</h3>
      <p>The cellular self-cleaning system that recycles damaged components loses efficiency with age.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">06</div>
      <h3>Deregulated Nutrient Sensing</h3>
      <p>Key metabolic pathways including mTOR, AMPK and sirtuins lose proper calibration, accelerating aging processes.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">07</div>
      <h3>Mitochondrial Dysfunction</h3>
      <p>The powerhouses of cells accumulate damage, producing less energy and more harmful reactive oxygen species.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">08</div>
      <h3>Cellular Senescence</h3>
      <p>Damaged cells that should die instead persist and secrete inflammatory signals that corrupt surrounding tissue.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">09</div>
      <h3>Stem Cell Exhaustion</h3>
      <p>The regenerative capacity of tissues declines as stem cell pools deplete and lose their functional properties.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">10</div>
      <h3>Altered Intercellular Communication</h3>
      <p>Signaling between cells degrades with age, disrupting coordinated tissue function and immune surveillance.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">11</div>
      <h3>Chronic Inflammation</h3>
      <p>Low-grade systemic inflammation — inflammaging — driven by senescent cells and immune dysfunction accelerates all other hallmarks.</p>
    </div>
    <div class="hallmark-card fade-in">
      <div class="hallmark-num">12</div>
      <h3>Dysbiosis</h3>
      <p>Imbalance in the gut microbiome disrupts metabolism, immunity, and systemic signaling contributing to accelerated aging.</p>
    </div>
  </div>
</section>

<!-- Interventions -->
<section class="interventions-section" id="interventions">
  <div class="section-label fade-in">02 — The Arsenal</div>
  <h2 class="fade-in">Current <em>Interventions</em></h2>

  <div class="tabs fade-in">
    <button class="tab-btn active" onclick="switchTab('senolytics', event)">Senolytics</button>
    <button class="tab-btn" onclick="switchTab('reprogramming', event)">Reprogramming</button>
    <button class="tab-btn" onclick="switchTab('mtor', event)">mTOR Inhibition</button>
    <button class="tab-btn" onclick="switchTab('nad', event)">NAD+ Restoration</button>
  </div>

  <div id="tab-senolytics" class="tab-content active">
    <div class="intervention-info">
      <h3>Senolytics</h3>
      <p>Senolytics selectively eliminate senescent cells — the "zombie cells" that accumulate with age, corrupting surrounding tissue through the senescence-associated secretory phenotype (SASP).</p>
      <p>Dasatinib + Quercetin, Navitoclax, and Fisetin represent the current leading senolytic compounds, with multiple clinical trials underway for age-related diseases.</p>
      <div class="intervention-meta">
        <div class="meta-item">
          <span class="meta-label">Status</span>
          <span class="meta-value">Clinical Trials</span>
        </div>
        <div class="meta-item">
          <span class="meta-label">Target Hallmark</span>
          <span class="meta-value">Cellular Senescence</span>
        </div>
        <div class="meta-item">
          <span class="meta-label">Animal Data</span>
          <span class="meta-value">Strong</span>
        </div>
        <div class="meta-item">
          <span class="meta-label">Human Data</span>
          <span class="meta-value">Emerging</span>
        </div>
      </div>
    </div>
    <div class="intervention-cards">
      <div class="intervention-card">
        <h4>Dasatinib + Quercetin</h4>
        <p>First senolytic combination shown to clear senescent cells in humans. Intermittent dosing protocol reduces systemic senescent cell burden.</p>
      </div>
      <div class="intervention-card">
        <h4>Navitoclax (ABT-263)</h4>
        <p>BCL-2 family inhibitor that selectively induces apoptosis in senescent cells by targeting their anti-apoptotic survival mechanisms.</p>
      </div>
      <div class="intervention-card">
        <h4>Fisetin</h4>
        <p>Naturally occurring flavonoid with senolytic properties. Lower toxicity profile makes it promising for long-term intermittent use.</p>
      </div>
    </div>
  </div>

  <div id="tab-reprogramming" class="tab-content">
    <div class="intervention-info">
      <h3>Epigenetic Reprogramming</h3>
      <p>Partial expression of Yamanaka factors (Oct4, Sox2, Klf4, c-Myc) can reverse epigenetic aging marks without causing full dedifferentiation — restoring youthful gene expression patterns.</p>
      <p>Considered the most transformative longevity approach by many researchers, as it targets upstream information loss rather than downstream damage.</p>
      <div class="intervention-meta">
        <div class="meta-item"><span class="meta-label">Status</span><span class="meta-value">Preclinical</span></div>
        <div class="meta-item"><span class="meta-label">Target</span><span class="meta-value">Epigenetic Clock</span></div>
        <div class="meta-item"><span class="meta-label">Animal Data</span><span class="meta-value">Very Strong</span></div>
        <div class="meta-item"><span class="meta-label">Risk</span><span class="meta-value">Tumorigenesis</span></div>
      </div>
    </div>
    <div class="intervention-cards">
      <div class="intervention-card">
        <h4>Altos Labs — OSK Reprogramming</h4>
        <p>$3B company developing safe partial reprogramming using Oct4, Sox2, Klf4 factors to restore youthful cellular identity.</p>
      </div>
      <div class="intervention-card">
        <h4>Chemical Reprogramming</h4>
        <p>Small molecule cocktails capable of inducing reprogramming without viral vectors — safer and more scalable delivery.</p>
      </div>
      <div class="intervention-card">
        <h4>In Vivo Reprogramming</h4>
        <p>Delivering reprogramming factors directly into living organisms via AAV vectors — the ultimate goal for systemic rejuvenation.</p>
      </div>
    </div>
  </div>

  <div id="tab-mtor" class="tab-content">
    <div class="intervention-info">
      <h3>mTOR Inhibition</h3>
      <p>Rapamycin and its analogs inhibit mTORC1, mimicking caloric restriction effects on aging. The most consistent life extension data in model organisms of any intervention.</p>
      <div class="intervention-meta">
        <div class="meta-item"><span class="meta-label">Status</span><span class="meta-value">Off-Label Use</span></div>
        <div class="meta-item"><span class="meta-label">Target</span><span class="meta-value">Nutrient Sensing</span></div>
        <div class="meta-item"><span class="meta-label">Animal Data</span><span class="meta-value">Excellent</span></div>
        <div class="meta-item"><span class="meta-label">Human Data</span><span class="meta-value">Promising</span></div>
      </div>
    </div>
    <div class="intervention-cards">
      <div class="intervention-card">
        <h4>Rapamycin</h4>
        <p>mTORC1 inhibitor extending lifespan in mice by 9-14% even when started late in life. Growing human longevity community uses it at low intermittent doses.</p>
      </div>
      <div class="intervention-card">
        <h4>Rapalogs</h4>
        <p>Second-generation mTOR inhibitors with improved selectivity profiles aiming to preserve benefits while reducing immunosuppression side effects.</p>
      </div>
    </div>
  </div>

  <div id="tab-nad" class="tab-content">
    <div class="intervention-info">
      <h3>NAD+ Restoration</h3>
      <p>NAD+ levels decline dramatically with age, impairing sirtuin activity, DNA repair, and mitochondrial function. Precursors NMN and NR can restore levels in humans.</p>
      <div class="intervention-meta">
        <div class="meta-item"><span class="meta-label">Status</span><span class="meta-value">Supplements + Trials</span></div>
        <div class="meta-item"><span class="meta-label">Target</span><span class="meta-value">Mitochondria + DNA Repair</span></div>
        <div class="meta-item"><span class="meta-label">Animal Data</span><span class="meta-value">Strong</span></div>
        <div class="meta-item"><span class="meta-label">Safety</span><span class="meta-value">Excellent</span></div>
      </div>
    </div>
    <div class="intervention-cards">
      <div class="intervention-card">
        <h4>NMN (Nicotinamide Mononucleotide)</h4>
        <p>Direct NAD+ precursor showing improvements in muscle function, insulin sensitivity, and NAD+ levels in human trials.</p>
      </div>
      <div class="intervention-card">
        <h4>NR (Nicotinamide Riboside)</h4>
        <p>Alternative NAD+ precursor with strong safety data and demonstrated ability to raise NAD+ levels in blood and tissues.</p>
      </div>
    </div>
  </div>
</section>

<!-- Roadmap -->
<section class="roadmap-section" id="roadmap">
  <div class="section-label fade-in">03 — The Timeline</div>
  <h2 class="fade-in">The Road to <em>Immortality</em></h2>
  <div class="timeline">
    <div class="timeline-item fade-in">
      <div class="timeline-year">NOW — 2030</div>
      <h3>The Compression Era</h3>
      <p>First senolytic therapies reach clinical approval. Rapamycin enters longevity trials. Partial reprogramming shows safety in primates. Biological age becomes a standard clinical biomarker. The first humans measurably reverse their biological age.</p>
    </div>
    <div class="timeline-item fade-in">
      <div class="timeline-year">2030 — 2040</div>
      <h3>The Rejuvenation Decade</h3>
      <p>Combination therapies targeting multiple hallmarks simultaneously achieve 20+ year biological age reversal in clinical settings. In vivo reprogramming reaches human trials. AI-designed longevity drugs accelerate breakthroughs. Longevity escape velocity enters serious scientific debate.</p>
    </div>
    <div class="timeline-item fade-in">
      <div class="timeline-year">2040 — 2050</div>
      <h3>Escape Velocity</h3>
      <p>For every year a person lives, science adds more than one year to their remaining life expectancy. The first generation to live indefinitely is already alive. Death from aging becomes a choice, not a certainty.</p>
    </div>
    <div class="timeline-item fade-in">
      <div class="timeline-year">2050+</div>
      <h3>The Post-Mortal World</h3>
      <p>Aging is classified as a fully treatable condition. The profound philosophical, societal, and ethical questions of indefinite lifespans become humanity's central challenge. Voveca's mission is complete.</p>
    </div>
  </div>
</section>

<!-- FAQ -->
<section class="faq-section" id="faq">
  <div class="section-label fade-in">04 — Questions</div>
  <h2 class="fade-in">Critical <em>Questions</em></h2>
  <div style="max-width:800px;">
    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>Is defeating aging actually scientifically possible?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          The scientific consensus has shifted dramatically. Aging is now understood as a biological process driven by identifiable molecular mechanisms — not a fixed law of nature. We have already reversed aging in model organisms. The 12 hallmarks provide a comprehensive mechanistic framework. The question is no longer "can we" but "how fast can we move."
        </div>
      </div>
    </div>
    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>What is longevity escape velocity?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          Longevity escape velocity (LEV) is the point at which science is extending human life expectancy faster than time passes. If you gain more than one year of healthy life expectancy for every year you live, you escape the mortality curve. Aubrey de Grey estimates LEV is achievable within decades with sufficient scientific investment.
        </div>
      </div>
    </div>
    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>Will AI dramatically accelerate longevity research?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          AlphaFold's protein structure predictions transformed structural biology overnight. Similar AI breakthroughs in aging research could compress decades of work into years. AI systems are already identifying novel drug candidates, predicting treatment outcomes, and designing clinical trials. The convergence of AI with aging biology may be the key catalyst.
        </div>
      </div>
    </div>
    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>What are the ethical implications of radical life extension?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          Profound questions arise: Will it only be available to the wealthy? How would overpopulation be managed? Proponents argue longevity would reduce suffering and allow accumulated wisdom. Equitable access and societal adaptation are as important as the science itself. These are problems worth having.
        </div>
      </div>
    </div>
    <div class="accordion-item fade-in">
      <div class="accordion-header" onclick="toggleAccordion(this)">
        <h4>Which single intervention has the greatest impact?</h4>
        <div class="accordion-icon">+</div>
      </div>
      <div class="accordion-body">
        <div class="accordion-body-inner">
          Epigenetic reprogramming is considered most transformative as it addresses upstream information loss. Senolytics offer the clearest near-term clinical benefit. mTOR inhibition has the most consistent animal data. A combination approach — senolytics, rapamycin, NAD+ precursors, epigenetic interventions — is the current leading hypothesis for near-term maximum benefit.
        </div>
      </div>
    </div>
  </div>
</section>

<!-- Companies -->
<section class="companies-section">
  <div class="section-label fade-in" style="justify-content:center;">05 — The Ecosystem</div>
  <h2 class="fade-in">Pioneering <em>Organizations</em></h2>
  <p class="fade-in" style="max-width:600px;margin:0 auto;">The longevity industry has attracted billions in investment. These organizations are pushing the frontier of aging science.</p>
  <div class="companies-grid fade-in">
    <div class="company-cell">
      <span class="company-name">ALTOS LABS</span>
      <span class="company-focus">Epigenetic Reprogramming</span>
      <span class="company-desc">$3B backed. Developing cellular rejuvenation programming to restore youthful biology.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">CALICO</span>
      <span class="company-focus">Longevity Research</span>
      <span class="company-desc">Google/Alphabet's longevity moonshot. Basic research into the biology of aging.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">UNITY BIOTECH</span>
      <span class="company-focus">Senolytics</span>
      <span class="company-desc">Clinical-stage company developing senolytic therapies for age-related diseases.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">RETRO BIOSCIENCES</span>
      <span class="company-focus">Reprogramming</span>
      <span class="company-desc">Sam Altman-backed. Partial cellular reprogramming and plasma dilution therapies.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">INSILICO MEDICINE</span>
      <span class="company-focus">AI Drug Discovery</span>
      <span class="company-desc">AI-powered aging target identification and drug candidate generation at scale.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">BIOAGE LABS</span>
      <span class="company-focus">Biomarkers + Drugs</span>
      <span class="company-desc">Machine learning on blood biomarkers to develop precision longevity therapies.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">SENS RESEARCH</span>
      <span class="company-focus">Damage Repair</span>
      <span class="company-desc">Targeting all 7 categories of age-related molecular damage for comprehensive repair.</span>
    </div>
    <div class="company-cell">
      <span class="company-name">NEWLIMIT</span>
      <span class="company-focus">Epigenetic Medicines</span>
      <span class="company-desc">Coinbase-backed. Building epigenetic medicines to extend healthy human lifespan.</span>
    </div>
  </div>
</section>

<!-- Manifesto -->
<section class="manifesto">
  <div class="manifesto-inner fade-in">
    <div class="section-label" style="justify-content:center;margin-bottom:40px;">Our Belief</div>
    <div class="manifesto-quote">
      "Death is not <em>inevitable.</em> Aging is not natural law. It is a disease — and every disease has a cure. The greatest project in human history has already begun."
    </div>
    <p style="color:var(--muted);font-size:16px;max-width:500px;margin:0 auto 40px;text-align:center;font-family:'Space Mono',monospace;letter-spacing:0.05em;line-height:1.8;">The science is ready. The technology is converging. The only question is: how fast can we move?</p>
    <a href="#aging" class="btn-primary"><span>Begin from the Start</span></a>
  </div>
</section>

<!-- Footer -->
<footer>
  <div class="footer-logo">
    <div class="footer-logo-dot"></div>
    VO<span>VE</span>CA
  </div>
  <div class="footer-text">
    An open-source longevity research hub<br>
    Built for the pursuit of human immortality
  </div>
  <div class="footer-founder">
    <strong>ALICE FROLOV</strong>
    Founder & Researcher
  </div>
  <div class="footer-links">
    <a href="#aging">Science</a>
    <a href="#interventions">Interventions</a>
    <a href="#roadmap">Roadmap</a>
    <a href="#faq">FAQ</a>
    <a href="#about">About</a>
  </div>
</footer>

<script>
  // Custom cursor
  const cursor = document.getElementById('cursor');
  const ring = document.getElementById('cursorRing');
  let mouseX = 0, mouseY = 0, ringX = 0, ringY = 0;

  document.addEventListener('mousemove', (e) => {
    mouseX = e.clientX;
    mouseY = e.clientY;
    cursor.style.left = mouseX - 4 + 'px';
    cursor.style.top = mouseY - 4 + 'px';
  });

  function animateRing() {
    ringX += (mouseX - ringX) * 0.12;
    ringY += (mouseY - ringY) * 0.12;
    ring.style.left = ringX + 'px';
    ring.style.top = ringY + 'px';
    requestAnimationFrame(animateRing);
  }
  animateRing();

  document.querySelectorAll('a, button, .accordion-header, .hallmark-card, .intervention-card, .company-cell').forEach(el => {
    el.addEventListener('mouseenter', () => {
      cursor.style.transform = 'scale(3)';
      ring.style.transform = 'translate(-50%, -50%) scale(1.5)';
      ring.style.borderColor = 'rgba(0,229,255,0.7)';
    });
    el.addEventListener('mouseleave', () => {
      cursor.style.transform = 'scale(1)';
      ring.style.transform = 'translate(-50%, -50%) scale(1)';
      ring.style.borderColor = 'rgba(0,229,255,0.4)';
    });
  });

  // Tabs
  function switchTab(name, event) {
    document.querySelectorAll('.tab-content').forEach(t => t.classList.remove('active'));
    document.querySelectorAll('.tab-btn').forEach(b => b.classList.remove('active'));
    document.getElementById('tab-' + name).classList.add('active');
    event.target.classList.add('active');
  }

  // Accordion
  function toggleAccordion(header) {
    const item = header.parentElement;
    const isOpen = item.classList.contains('open');
    document.querySelectorAll('.accordion-item').forEach(i => i.classList.remove('open'));
    if (!isOpen) item.classList.add('open');
  }

  // Scroll animations
  const observer = new IntersectionObserver((entries) => {
    entries.forEach(entry => {
      if (entry.isIntersecting) entry.target.classList.add('visible');
    });
  }, { threshold: 0.1, rootMargin: '0px 0px -50px 0px' });

  document.querySelectorAll('.fade-in').forEach(el => observer.observe(el));

  // Counter animation
  function animateCounter(el, target, prefix = '', suffix = '') {
    let current = 0;
    const duration = 2000;
    const step = target / (duration / 16);
    const timer = setInterval(() => {
      current += step;
      if (current >= target) { current = target; clearInterval(timer); }
      el.textContent = prefix + Math.round(current) + suffix;
    }, 16);
  }

  const statsObserver = new IntersectionObserver((entries) => {
    entries.forEach(entry => {
      if (entry.isIntersecting) {
        animateCounter(document.getElementById('stat1'), 150, '', 'T');
        animateCounter(document.getElementById('stat2'), 12, '', '');
        animateCounter(document.getElementById('stat3'), 5, '$', 'B+');
        animateCounter(document.getElementById('stat4'), 2050, '', '');
        statsObserver.disconnect();
      }
    });
  }, { threshold: 0.5 });

  const statsBar = document.querySelector('.stats-bar');
  if (statsBar) statsObserver.observe(statsBar);

  // Nav scroll
  window.addEventListener('scroll', () => {
    const nav = document.querySelector('nav');
    if (window.scrollY > 100) {
      nav.style.background = 'rgba(3,5,8,0.97)';
      nav.style.borderBottom = '1px solid rgba(0,229,255,0.08)';
    } else {
      nav.style.background = 'linear-gradient(to bottom, rgba(3,5,8,0.95), transparent)';
      nav.style.borderBottom = 'none';
    }
  });
</script>
</body>
</html>